These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20833330)

  • 1. Multiple endocrine neoplasia type 2.
    Wohllk N; Schweizer H; Erlic Z; Schmid KW; Walz MK; Raue F; Neumann HP
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):371-87. PubMed ID: 20833330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
    Frank-Raue K; Rondot S; Schulze E; Raue F
    Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
    Machens A; Dralle H
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
    Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2.
    Gujral TS; Mulligan LM
    Ann N Y Acad Sci; 2006 Aug; 1073():234-40. PubMed ID: 17102091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
    Kousseff BG
    Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
    Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family].
    Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L
    Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
    Frank-Raue K; Rondot S; Raue F
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 2.
    Peczkowska M; Januszewicz A
    Fam Cancer; 2005; 4(1):25-36. PubMed ID: 15883707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
    Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
    Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.